Nordic Life Science 1
TOP STORIES BUSINESS Linn Wrangmark and Frida McC
abe Francois Martelet, CEO, Oasmia Árni Sigurjónsson, Chairman of SI, Guðlaugur Þór Þórðarson, Minister of Foreign Affairs, Jónína Guðmundsdóttir, CEO of Coripharma, and Sigurður Hannesson, CEO of SI – The Federation of Icelandic Industries. is to finance awarded by Gudlaugur Thor Thordarson, Minister for Foreign Affairs of Iceland, is a collaborative project of The Federation of Icelandic Industries, The Association of Start-up companies, Reykjavik University, and the Icelandic Centre for Research. The purpose of this project is to embrace and draw attention to fast-growing start-up companies and their positive industry development. the continued development of the company and its projects in accordance with its business plan and strategy. Oasmia has adopted a growth strategy focusing on broadening the pipeline through acquisition and in-licensing of additional oncology assets. In 2021, Oasmia initiated the first step of strategy through the acquisition of clinical stage oncology asset Cantrixil. The proposed new name, Vivesto reflects the company’s commitment to enhancing quality of life for patients with cancer, and its focus on R&D and innovation, the Board of Directors state. “Vivesto reflects our optimism for the future and our commitment to improving survival and quality of life for patients with hard-to-treat and late-stage cancers through R&D and innovation,” says Francois Martelet, CEO, Oasmia. 14 NORDICLIFESCIENCE.ORG PHOTO SI PHOTO FELIX OPPENHEIM